Biography - Alexandra Leary

Professor Alexandra Leary is an oncologist specializing in gynecologic cancers and the head of the Gynecology Committee at Gustave Roussy. She also chairs the GINECO group, which focuses on clinical trials in gynecologic oncology. Her expertise focuses on the early-stage development of drugs for ovarian, cervical, and endometrial cancers. She trained in medical oncology at the Royal Marsden Hospital in London and earned a Ph.D. in molecular biology from the Institute of Cancer Research at the University of London.

In addition to her clinical work, Prof. Leary leads the translational research team in gynecologic oncology at the Molecular Predictors and New Targets in Oncology laboratory (INSERM U981) at Gustave Roussy, and teaches medicine at Paris-Saclay University.

Internationally recognized, Prof. Leary is a member of the translational research group of the European Network for Gynaecological Oncological Trials (ENGOT) and serves on the strategic committee of the Gynecological Cancer InterGroup (GCIG), where she also co-chairs the Phase II Clinical Trials Group. She is a faculty member of the European Society of Medical Oncology (ESMO) and served as program chair for gynecology at ESMO 2022 and ESMO Asia 2023.

She is the principal investigator or co-investigator on nearly 100 Phase I, II, and III clinical trials. She is also the scientific coordinator of the MOSAIC project and coordinates the Real Life Trial initiative in collaboration with the CRIS Cancer Foundation in Barcelona.

Prof. Leary is the author or co-author of more than 200 publications in international peer-reviewed journals, including The Lancet, the New England Journal of Medicine, the Journal of Clinical Oncology, and Clinical Cancer Research.